首頁 > 市場調查報告書 > 製藥

解剖病理追蹤溯源解決方案市場規模、佔有率和成長分析：按解決方案類型、組件、技術、最終用戶、應用、部署模式和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2091500

解剖病理追蹤溯源解決方案市場規模、佔有率和成長分析：按解決方案類型、組件、技術、最終用戶、應用、部署模式和地區分類－2026-2033年產業預測

Anatomic Pathology Track and Trace Solutions Market Size, Share, and Growth Analysis, By Solution Type, By Component, By Technology, By End User, By Application, By Deployment Mode, By Region - Industry Forecast 2026-2033

出版日期: 2026年07月14日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球解剖病理學可追溯性解決方案市值為 4.873 億美元，預計到 2033 年將從 2025 年的 5.3506 億美元成長到 11.3037 億美元，預測期（2026-2033 年）的複合年成長率為 9.8%。

受成本削減和個人化醫療日益普及的推動，解剖病理學領域的追蹤溯源解決方案市場正經歷顯著成長。醫療機構擴大採用數位化檢體追蹤系統，以提高檢查室效率、降低營運成本並確保診斷準確性。有效的追蹤能夠最大限度地減少標籤錯誤、防止檢體遺失並減少重複切片檢查的需求，最終縮短檢測結果報告時間並提高病患安全。隨著精準醫療的進步，分子診斷和生物標記分析中對準確檢體溯源的需求至關重要，這促使醫院和檢查室投資於整合條碼和RFID技術以及實驗室資訊系統的追蹤溯源解決方案。此外，人工智慧和物聯網的進步正在簡化營運流程，並在不斷變化的市場環境中提升整體效率。

全球解剖病理學追蹤溯源解決方案市場按解決方案類型、組件、技術、最終用戶、應用、部署模式和地區進行細分。依解決方案類型分類，市場分為檢體追蹤解決方案、資產追蹤解決方案和端到端追蹤溯源解決方案。按組件分類，市場分為軟體、硬體和服務。按技術分類，市場分為基於條碼的解決方案、基於RFID的解決方案和混合解決方案。按最終用戶分類，市場分為醫院、診斷檢查室、大學醫學中心和其他機構。按應用分類，市場分為檢體識別、檢體處理管理、工作流程管理和其他應用。依部署模式分類，市場分為雲端部署、本地部署和混合部署。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

解剖病理學可追溯性解決方案全球市場的成長要素。

全球解剖病理學追蹤溯源解決方案市場正受到檢查室雲端平台日益普及的顯著推動。這些平台簡化了資料存儲，增強了檢體追蹤能力，促進了不同機構間跨越地域的無縫協作。這項進步減少了營運瓶頸，並確保符合監管標準。此外，雲端解決方案的柔軟性支援實驗室快速擴展容量，同時提升資料完整性並降低基礎設施成本。隨著各機構逐漸認知到將全面的追蹤溯源解決方案整合到工作流程中的益處，市場成長正在加速。先進的分析功能提供了寶貴的洞察，使病理學家能夠最佳化診斷流程，並增強了人們對採用尖端溯源技術的信心。

全球解剖病理學追蹤溯源解決方案市場面臨的限制因素。

由於高成本，全球解剖病理學可追溯性解決方案市場面臨嚴峻挑戰。許多病理檢查室，尤其是規模小規模或預算有限的機構，難以承擔必要的硬體、軟體許可和整合服務所需的大量前期投資。持續的維護成本和專業培訓需求進一步加重了財務負擔，並增加了整體擁有成本。因此，許多機構可能會推遲或限制對可追溯性系統的投資，最終導致市場滲透率下降，並延緩整個診斷生態系統效率提升的實現。預算限制往往迫使團隊優先考慮眼前的臨床需求，而非長期的可追溯性計畫。

全球解剖病理學可追溯性解決方案市場趨勢

全球解剖病理學可追溯性解決方案市場正呈現顯著成長趨勢，這主要得益於病理檢查室對人工智慧技術的快速應用。隨著各機構部署人工智慧輔助平台進行常規切片分析，病例分診速度加快，診斷準確率顯著提高。這些人工智慧工具利用大量影像資料集，能夠辨識經驗豐富的專業人員可能忽略的細微形態學徵兆。此外，互通性應用程式介面（API）的進步確保了與電子健康記錄的無縫整合，從而加強了醫療協調。這些效率的提升和良好的患者預後正在推動人工智慧的廣泛應用，使其成為解剖病理學工作流程發展中不可或缺的關鍵要素。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Leica Biosystems Nussloch GmbH
Roche Diagnostics International AG
Sakura Finetek Japan Co., Ltd.
Hamamatsu Photonics KK
Inspirata, Inc.
Gestalt Diagnostics, Inc.
Sectra AB
Philips Digital & Computational Pathology
Indica Labs, Inc.
Proscia Inc.
XIFIN, Inc.
PathAI, Inc.
Visiopharm A/S
3DHISTECH Ltd.
CompuGroup Medical SE & Co. KGaA
Clinisys Group GmbH
Sunquest Information Systems, Inc.
LabVantage Solutions, Inc.
MIPS Informatics GmbH
Aiforia Technologies Plc

結論與建議

簡介目錄

Product Code: SQMIG35J2514

Global Anatomic Pathology Track And Trace Solutions Market size was valued at USD 487.3 Million in 2024 and is poised to grow from USD 535.06 Million in 2025 to USD 1130.37 Million by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The Anatomic Pathology Track and Trace Solutions market is experiencing significant growth fueled by cost containment efforts and a heightened emphasis on personalized medicine. Healthcare providers increasingly adopt digital specimen tracking systems to enhance lab efficiency, reduce operational costs, and ensure accurate diagnostics. Effective tracking minimizes labeling errors, prevents sample loss, and decreases the need for repeat biopsies, ultimately speeding up turnaround times and improving patient safety. As precision medicine advances, the necessity for accurate specimen traceability in molecular diagnostics and biomarker analysis becomes paramount, prompting hospitals and labs to invest in integrated track and trace solutions that incorporate barcode or RFID technologies alongside laboratory information systems. Additionally, advancements in AI and IoT are streamlining operations and enhancing overall efficiency in this evolving market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Anatomic Pathology Track And Trace Solutions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Anatomic Pathology Track And Trace Solutions Market Segments Analysis

The global anatomic pathology track and trace solutions market is segmented by solution type, component, technology, end user, application, deployment mode and region. Based on solution type, the market is segmented into Specimen Tracking Solutions, Asset Tracking Solutions and End-to-End Track & Trace Solutions. Based on component, the market is segmented into Software, Hardware and Services. Based on technology, the market is segmented into Barcode-Based Solutions, RFID-Based Solutions and Hybrid Solutions. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Academic Medical Centers and Others. Based on application, the market is segmented into Specimen Identification, Chain of Custody Management, Workflow Management and Others. Based on deployment mode, the market is segmented into Cloud-Based, On-Premises and Hybrid. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Anatomic Pathology Track And Trace Solutions Market

The global market for anatomic pathology track and trace solutions is significantly driven by the increasing adoption of cloud platforms in laboratories. These platforms streamline data storage and enhance sample tracking, fostering seamless collaboration among facilities regardless of their geographical proximity. This advancement reduces operational bottlenecks and ensures compliance with regulatory standards. Additionally, the flexibility offered by cloud solutions facilitates rapid scaling of testing capacities while enhancing data integrity and lowering infrastructure costs. As institutions recognize the benefits of integrating comprehensive track and trace solutions into their workflows, market growth accelerates. Furthermore, advanced analytics provide valuable insights, empowering pathologists to optimize diagnostic processes and bolstering confidence in the adoption of cutting-edge traceability technologies.

Restraints in the Global Anatomic Pathology Track And Trace Solutions Market

The Global Anatomic Pathology Track and Trace Solutions market faces significant challenges due to the high costs associated with implementation. Many pathology laboratories, particularly smaller facilities or those with constrained budgets, struggle with the substantial initial investments required for necessary hardware, software licenses, and integration services. Ongoing maintenance fees and the need for specialized training further exacerbate the financial burden, increasing the total cost of ownership. Consequently, numerous organizations may defer or limit their investments in track and trace systems, which ultimately slows market penetration and delays the realization of efficiency benefits throughout the broader diagnostic ecosystem. Budget constraints often compel teams to prioritize immediate clinical needs over long-term commitments to traceability.

Market Trends of the Global Anatomic Pathology Track And Trace Solutions Market

The Global Anatomic Pathology Track and Trace Solutions market is experiencing a notable trend driven by the rapid integration of AI technologies within pathology labs. As facilities adopt AI-assisted platforms for routine slide analysis, the capacity for expedited case triage and enhanced diagnostic accuracy is improving. Leveraging vast image datasets, these AI tools identify subtle morphologic signals that may be overlooked by even seasoned professionals. Furthermore, the push for interoperable APIs ensures seamless integration with electronic health records, enhancing care coordination. These efficiency gains and promising patient outcomes are fostering widespread adoption, positioning AI as an essential component in the evolution of anatomic pathology workflows.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Anatomic Pathology Track and Trace Solutions Market Size by Solution Type & CAGR (2026-2033)

Market Overview
Specimen Tracking Solutions
Asset Tracking Solutions
End-to-End Track & Trace Solutions

Global Anatomic Pathology Track and Trace Solutions Market Size by Component & CAGR (2026-2033)

Market Overview
Software
Hardware
Services

Global Anatomic Pathology Track and Trace Solutions Market Size by Technology & CAGR (2026-2033)

Market Overview
Barcode-Based Solutions
RFID-Based Solutions
Hybrid Solutions

Global Anatomic Pathology Track and Trace Solutions Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Laboratories
Academic Medical Centers
Others

Global Anatomic Pathology Track and Trace Solutions Market Size by Application & CAGR (2026-2033)

Market Overview
Specimen Identification
Chain of Custody Management
Workflow Management
Others

Global Anatomic Pathology Track and Trace Solutions Market Size by Deployment Mode & CAGR (2026-2033)

Market Overview
Cloud-Based
On-Premises
Hybrid

Global Anatomic Pathology Track and Trace Solutions Market Size & CAGR (2026-2033)

North America (Solution Type, Component, Technology, End User, Application, Deployment Mode)
- US
- Canada
Europe (Solution Type, Component, Technology, End User, Application, Deployment Mode)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Solution Type, Component, Technology, End User, Application, Deployment Mode)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Solution Type, Component, Technology, End User, Application, Deployment Mode)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Solution Type, Component, Technology, End User, Application, Deployment Mode)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Leica Biosystems Nussloch GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics International AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sakura Finetek Japan Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamamatsu Photonics K.K.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inspirata, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gestalt Diagnostics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sectra AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Digital & Computational Pathology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indica Labs, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proscia Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
XIFIN, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PathAI, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Visiopharm A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3DHISTECH Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CompuGroup Medical SE & Co. KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinisys Group GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sunquest Information Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabVantage Solutions, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MIPS Informatics GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aiforia Technologies Plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments